Bio-Rad Laboratories, Inc. (BIO)

Bio-Rad Laboratories Stock Forecast

Stock Price Forecast

The 4 analysts with 12-month price forecasts for BIO stock have an average target of 414, with a low estimate of 340 and a high estimate of 481. The average target predicts an increase of 26.42% from the current stock price of 327.47.

Analyst Consensus: Strong Buy

Target	Low	Average	Median	High
Price	$340	$414	$450	$481
Change	+3.83%	+26.42%	+37.42%	+46.88%

Analyst Ratings

The average analyst rating for BIO stock from 4 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.

Recommendation Trends

Rating	Jul '24	Aug '24	Sep '24	Oct '24	Nov '24	Dec '24
Strong Buy	1	1	1	2	2	2
Buy	1	1	1	1	1	1
Hold	1	2	2	1	1	1
Sell	0	0	0	0	0	0
Strong Sell	0	0	0	0	0	0
Total	3	4	4	4	4	4

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Conor McNamara RBC Capital	RBC Capital	Buy Maintains $369 → $481	Buy	Maintains	$369 → $481	+46.88%	Dec 9, 2024
Patrick Donnelly Citigroup	Citigroup	Strong Buy Maintains $400 → $450	Strong Buy	Maintains	$400 → $450	+37.42%	Oct 31, 2024
Conor McNamara RBC Capital	RBC Capital	Buy Maintains $446 → $469	Buy	Maintains	$446 → $469	+43.22%	Oct 31, 2024
Patrick Donnelly Citigroup	Citigroup	Hold → Strong Buy Upgrades $350 → $400	Hold → Strong Buy	Upgrades	$350 → $400	+22.15%	Oct 1, 2024
Brandon Couillard Wells Fargo	Wells Fargo	Hold Initiates $340	Hold	Initiates	$340	+3.83%	Aug 27, 2024

More Analyst Ratings

Financial Forecast

Revenue This Year

2.61B

Decreased by -2.48%

from 2.67B

Revenue Next Year

2.68B

Increased by 2.92%

from 2.61B

EPS This Year

10.39

from -21.82

EPS Next Year

11.63

Increased by 11.93%

from 10.39

Fiscal Year	FY 2019	FY 2020	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026
Period Ending	Dec 31, 2019	Dec 31, 2020	Dec 31, 2021	Dec 31, 2022	Dec 31, 2023	Dec 31, 2024	Dec 31, 2025	Dec 31, 2026
Revenue	2.31B	2.55B	2.92B	2.80B	2.67B	2.61B	2.68B	2.81B
Revenue Growth	0.97%	10.12%	14.81%	-4.12%	-4.67%	-2.48%	2.92%	4.85%
EPS	58.27	126.47	140.83	-121.79	-21.82	10.39	11.63	13.21
EPS Growth	381.57%	117.04%	11.35%	-	-	-	11.93%	13.63%
Forward PE	-	-	-	-	-	31.52	28.16	24.78
No. Analysts	-	-	-	-	-	9	9	7

Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue	2024	2025	2026	2027	2028
High	2.7B	2.8B	2.9B
Avg	2.6B	2.7B	2.8B
Low	2.5B	2.6B	2.7B

Revenue Growth

Revenue Growth	2024	2025	2026	2027	2028
High	1.6%	7.5%	10.0%
Avg	-2.5%	2.9%	4.8%
Low	-5.6%	-1.0%	-

EPS Forecast

EPS	2024	2025	2026	2027	2028
High	10.91	12.36	14.07
Avg	10.39	11.63	13.21
Low	9.90	10.98	12.49

EPS Growth

EPS Growth	2024	2025	2026	2027	2028
High	-	19.0%	21.0%
Avg	-	11.9%	13.6%
Low	-	5.7%	7.4%

Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.